Viewing data from:

HALOPERIDOL

ANDA

HALOPERIDOL | A071130 | AIPING PHARMACEUTICAL INC

6 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 12 NDCs

Highest NADAC/Unit

$0.3734

per ea

Lowest NADAC/Unit

$0.0939

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
11788007601HALOPERIDOL 20 MG TABLET	$0.3734	EA	Generic	—	2026-08-19
11788007610HALOPERIDOL 20 MG TABLET	$0.3734	EA	Generic	—	2026-08-19
11788007401HALOPERIDOL 5 MG TABLET	$0.1782	EA	Generic	—	2026-08-19
11788007410HALOPERIDOL 5 MG TABLET	$0.1782	EA	Generic	—	2026-08-19
11788007301HALOPERIDOL 2 MG TABLET	$0.1579	EA	Generic	—	2026-08-19
11788007310HALOPERIDOL 2 MG TABLET	$0.1579	EA	Generic	—	2026-08-19

Showing 6 of 12 NDCs.

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain7 active DMFs6 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVHALOPERIDOL

DMF 49911983

JANSSEN PHARMACEUTICA NVHALOPERIDOL (R001625) DRUG SUBSTANCE

DMF 109461994

EXCELLA GMBH AND CO KGHALOPERIDOL

DMF 142261999

OLON SPAHALOPERIDOL

DMF 245852011

MSN LIFE SCIENCES PRIVATE LTDHALOPERIDOL USP

DMF 336922019

MANKIND PHARMA LTDHALOPERIDOL USP

DMF 341902019

VAMSI LABS LTDHALOPERIDOL USP

DMF 342832019

A NATTERMANN AND CIE GMBHInactiveHALOPERIDOL

DMF 53641984

ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVInactiveHALOPERIDOL

DMF 62001986

IMHAUSEN CHEMIE GMBHInactiveHALOPERIDOL

DMF 68001987

GD SEARLE AND COInactiveHALOPERIDOL

DMF 71571987

HEUMANN PCS GMBHInactiveHALOPERIDOL

DMF 74861988

RPG LIFE SCIENCES LTDInactiveHALOPERIDOL USP

DMF 233112009

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (6)

Sort:

#001 — 2MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Feb 17, 1987

No patent or exclusivity listings for this strength.

#002 — 5MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Feb 17, 1987

#003 — 10MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: May 12, 1987

#004 — 0.5MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 8, 2026

#005 — 1MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 8, 2026

#006 — 20MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 8, 2026